Sai Kottapalli
Vascular Surgery · Las Vegas, NVNPI 1396278479
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (35.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Shockwave Medical, Inc at 46.8% of the total. Reporting peaked in 2024 at $29,045 and has fallen 61.5% since, to $11,186 in 2025. Among vascular surgery clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $217.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$25K
- Penumbra, Inc.$10K
- Boston Scientific$7K
- W. L. Gore & Associates, Inc.$6K
- Endologix LLC$1K
- Silk Road Medical, Inc.$920
- plus $3K from 16 others
What the payments were for
- Consulting fees$12,31323%
- Speaking & faculty fees$19,00036%
- Travel & lodging$5,47410%
- Food & beverage$15,94030%
- Education$4621%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 34 | $24,886 |
| Penumbra, Inc. | 44 | $9,759 |
| Boston Scientific | 37 | $7,340 |
| W. L. Gore & Associates, Inc. | 61 | $6,174 |
| Endologix LLC | 7 | $1,031 |
| Silk Road Medical, Inc. | 7 | $920 |
| Bolton Medical Inc | 7 | $695 |
| Surmodics, Inc. | 3 | $480 |
| Angiodynamics, Inc. | 3 | $426 |
| Lemaitre Vascular, Inc. | 7 | $268 |
| Inari Medical, Inc. | 4 | $258 |
| Cook Medical LLC | 5 | $208 |
| Microtransponder, Inc. | 1 | $144 |
| Reflow Medical Inc | 1 | $142 |
| Pfizer | 7 | $126 |
| Philips North America LLC | 3 | $84 |
| Johnson & Johnson | 4 | $77 |
| Kerecis Limited | 4 | $68 |
| Tactile Systems Technology Inc | 2 | $38 |
| Veryan Medical Incorporated | 1 | $29 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Inspiremd Ltd | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$24,565
- Indigo System$8,728
- ENROUTE Transcarotid Neuroprotection System$1,397
- GORE TAG Thoracic Endoprosthesis$1,368
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$1,308
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$871
- GORE TAG Thoracic Branch Endoprosthesis$787
- ENROUTE Transcarotid Stent$773
- Alto Abdominal Stent Graft System$659
- GORE TAG Conformable Thoracic Endoprosthesis$617
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$509
- Sublime 014 Rx PTA Balloon Dilatation Catheter$480
- Sublime Microcatheter, 018, 200cm, Straight$480
- Pounce Thrombectomy System$480
- Pounce Thrombectomy$480
- Pounce Venous Thrombectomy System$480
- Auryon Laser System 100-120 Vac$355
- ENDOCROSS Device$285
- Torus Stent Graft System$285
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$199
How this compares
$53,189 in reported general payments places this provider in the 90th percentile of 28 vascular surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $16,874 |
| ClopidogrelClopidogrel Bisulfate | 88 | $623 |
| Gabapentin | 37 | $580 |
| Cilostazol | 15 | $174 |
| Atorvastatin Calcium | 13 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $126 | $16,87427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 28 vascular surgery providers in Nevada.
Other vascular surgery in Las Vegas
- George PliagasLas Vegas$211K
- Eddy LuhLas Vegas$34K
- Earl CottrellLas Vegas$30K
- Bruce HirschfeldLas Vegas$28K
- Alvancin LouisLas Vegas$17K
- Amir GhaffarianLas Vegas$14K
- Rohan KulkarniLas Vegas$9K
- Alexander GidayaLas Vegas$9K
- Alex LallLas Vegas$8K
- Peter LeeLas Vegas$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.